We are proud to announce the 3rd edition of the Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV, scheduled to take place on 27 – 28 September 2017 in Ljubljana, Slovenia.
The Central and Eastern European Meeting on Viral Hepatitis and Co-infection is an independent program, initiated in 2014 and developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral Hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of Hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries. This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV.
The target audience of this meeting consists of healthcare professionals involved in daily care for HCV patients such as infectious disease doctors, gastro-enterologists, hepatologists and others.
Wednesday 27 September |
|
| 09.00 | Opening of the meeting |
| Session 1: Epidemiology / Access to Treatment Chairs: |
|
| 09.10 | Local situation in Balkan Countries Speaker to be confirmed |
| 09.20 | Local situation in Ukraine Speaker to be confirmed |
| 09.30 | Local situation in Russia Speaker to be confirmed |
| 09.40 | Local situation in Romania Speaker to be confirmed |
| 09.50 | Local situation in Baltic Countries Speaker to be confirmed |
| 10.00 | Local situation in Georgia Speaker to be confirmed |
| 10.10 | Local situation in Czech and Slovak Republics Speaker to be confirmed |
| 10.20 | Local situation in Turkey Speaker to be confirmed |
| 10.30 | Local situation in Poland Andrzej Horban, MD, PhD University of Warsaw, Poland |
| 10.45 | Coffee Break |
| 11.15 | Hep-CORE study: Management of HBV and HCV infections throughout Europe Jeffrey Lazarus, PhD Copenhagen University Hospital, Denmark |
| 11.40 | New Testing Strategies for HCV: how can we achieve the WHO targets? Mario Poljak, MD, PhD University of Ljubljana, Slovenia |
| 12.05 | Round Table Discussion: Access to hepC treatment Participants to be confirmed |
| 13.00 | Lunch |
| 14.00 Industry-sponsored symposium | |
| Session 2: Management of HCC in HCV infected patients Chairs: |
|
| 15.00 | Invited lecture Markus Peck-Radosavljevic, MD Klinikum Klagenfurt am Wörthersee, Austria |
| 15.30 | Clinical Case (HCV related) Speaker to be confirmed |
| 16.00 | Coffee break |
| 16.30 Industry-sponsored symposium | |
| 17.30 | Abstract – driven presentations |
| 18.00 | Welcome reception & Poster viewing |
| 19.00 | Networking dinner |
Thursday 28 September |
|
| 08.00 Industry-sponsored symposium | |
| Session 3: Treatment Challenges in HIV &HCV – Special Populations Chairs: |
|
| 9.00 | Challenge in PWID Mojca Maticic, MD, PhD University of Ljubljana, Slovenia |
| 9.30 | Special challenges in curbing the HIV epidemic in Central/Eastern Europe Speaker to be confirmed |
| 10.00 | Coffee Break |
| Session 4: Epidemiology, Clinical presentation and Management of Hepatitis E Virus Chairs: |
|
| 10.30 | Invited lecture Heiner Wedemeyer, MD Medical School Hannover, Germany |
| 11.00 | Abstract – driven presentations |
| Special session: Future directions of ARVs Chairs: |
|
| 12.00 | Virologist perspective Speaker to be confirmed |
| 12.15 | Clinician perspective Speaker to be confirmed |
| 12.30 | Pharmacologist perspective Speaker to be confirmed |
| 12.45 | Discussion |
| 13.00 | Lunch |
| Session 5: Future in Diagnostic & Therapeutic Approaches Chairs: |
|
| 13.45 | The challenges in hepatitis B vaccination Pierre Van Damme, MD, PhD University of Antwerp, Belgium |
| 14.15 | Innovative diagnostics for HIV, HBV and HCV Dan Otelea, MD, Phd Nat. Institute for Inf. Diseases “Prof. Dr. Matei Bals”, Romania |
| 14.45 | Discussion |
| 15.00 | Closing remarks |
The members of the Organizing Committee (OC) discuss, on a frequent basis, the scientific programme of the workshop, identify interesting topics and candidate speakers and review all submitted abstracts.
